The Immortalized UROtsa Cell Line as a Potential Cell Culture Model of Human Urothelium

The UROtsa cell line was isolated from a primary culture of normal human urothelium through immortalization with a construct containing the SV40 large T antigen. It proliferates in serum-containing growth medium as a cell monolayer with little evidence of uroepithelial differentiation. The working h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Environmental health perspectives Jg. 109; H. 8; S. 801 - 808
Hauptverfasser: Rossi, Michael R., John R. W. Masters, Park, Seongmi, Todd, John H., Garrett, Scott H., Sens, Mary Ann, Somji, Seema, Nath, Joginder, Sens, Donald A.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States National Institute of Environmental Health Sciences. National Institutes of Health. Department of Health, Education and Welfare 01.08.2001
National Institute of Environmental Health Sciences
Schlagworte:
ISSN:0091-6765, 1552-9924
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract The UROtsa cell line was isolated from a primary culture of normal human urothelium through immortalization with a construct containing the SV40 large T antigen. It proliferates in serum-containing growth medium as a cell monolayer with little evidence of uroepithelial differentiation. The working hypothesis in the present study was that this cell line could be induced to differentiate and express known features of in situ urothelium if the original serum-containing growth medium was changed to a serum-free formulation. We demonstrated that the UROtsa cells could be successfully placed into a serum-free growth medium consisting of a 1:1 mixture of Dulbeco's modified Eagle's medium and Ham's F-12 supplemented with selenium (5 ng/mL), insulin (5 μg/mL), transferrin (5 μg/mL), hydrocortisone (36 ng/mL), triiodothyronine (4 pg/mL), and epidermal growth factor (10 ng/mL). Under serum-free growth conditions, confluent UROtsa cells were shown by light microscopy to produce raised, three-dimensional structures. Routine ultrastructural examination disclosed these three-dimensional areas to consist of a stratified layer of cells that strongly resembled in situ urothelium. The cells displayed numerous desmosomal connections, complex interactions of the lateral membranes, and abundant intermediate filaments within the cytoplasm. Freeze fracture analysis demonstrated that the cells possessed tight-junction sealing strands and gap junctions. The overall morphology was most consistent with that found in the intermediate layers of in situ urothelium. The basal expression patterns of the metallothionein (MT) and heat shock proteins 27, 60, and 70 were determined in these cells, and expression was in agreement with that known to occur for in situ urothelium. The cells were also successfully tested for their ability to be stably transfected using expression vectors containing the MT-3 or MT-2A genes. The findings suggest that the UROtsa cells grown with a serum-free medium could be a valuable adjunct for studying environmental insult to the human urothelium in general and for the stress response in particular.
AbstractList The UROtsa cell line was isolated from a primary culture of normal human urothelium through immortalization with a construct containing the SV40 large T antigen. It proliferates in serum-containing growth medium as a cell monolayer with little evidence of uroepithelial differentiation. The working hypothesis in the present study was that this cell line could be induced to differentiate and express known features of in situ urothelium if the original serum-containing growth medium was changed to a serum-free formulation. We demonstrated that the UROtsa cells could be successfully placed into a serum-free growth medium consisting of a 1:1 mixture of Dulbeco's modified Eagle's medium and Ham's F-12 supplemented with selenium (5 ng/mL), insulin (5 mu g/mL), transferrin (5 mu g/mL), hydrocortisone (36 ng/mL), triiodothyronine (4 pg/mL), and epidermal growth factor (10 ng/mL). Under serum-free growth conditions, confluent UROtsa cells were shown by light microscopy to produce raised, three-dimensional structures. Routine ultrastructural examination disclosed these three-dimensional areas to consist of a stratified layer of cells that strongly resembled in situ urothelium. The cells displayed numerous desmosomal connections, complex interactions of the lateral membranes, and abundant intermediate filaments within the cytoplasm. Freeze fracture analysis demonstrated that the cells possessed tight-junction sealing strands and gap junctions. The overall morphology was most consistent with that found in the intermediate layers of in situ urothelium. The basal expression patterns of the metallothionein (MT) and heat shock proteins 27, 60, and 70 were determined in these cells, and expression was in agreement with that known to occur for in situ urothelium. The cells were also successfully tested for their ability to be stably transfected using expression vectors containing the MT-3 or MT-2A genes. The findings suggest that the UROtsa cells grown with a serum-free medium could be a valuable adjunct for studying environmental insult to the human urothelium in general and for the stress response in particular.
The UROtsa cell line was isolated from a primary culture of normal human urothelium through immortalization with a construct containing the SV40 large T antigen. It proliferates in serum-containing growth medium as a cell monolayer with little evidence of uroepithelial differentiation. The working hypothesis in the present study was that this cell line could be induced to differentiate and express known features of in situ urothelium if the original serum-containing growth medium was changed to a serum-free formulation. We demonstrated that the UROtsa cells could be successfully placed into a serum-free growth medium consisting of a 1:1 mixture of Dulbeco's modified Eagle's medium and Ham's F-12 supplemented with selenium (5 ng/mL), insulin (5 μg/mL), transferrin (5 μg/mL), hydrocortisone (36 ng/mL), triiodothyronine (4 pg/mL), and epidermal growth factor (10 ng/mL). Under serum-free growth conditions, confluent UROtsa cells were shown by light microscopy to produce raised, three-dimensional structures. Routine ultrastructural examination disclosed these three-dimensional areas to consist of a stratified layer of cells that strongly resembled in situ urothelium. The cells displayed numerous desmosomal connections, complex interactions of the lateral membranes, and abundant intermediate filaments within the cytoplasm. Freeze fracture analysis demonstrated that the cells possessed tight-junction sealing strands and gap junctions. The overall morphology was most consistent with that found in the intermediate layers of in situ urothelium. The basal expression patterns of the metallothionein (MT) and heat shock proteins 27, 60, and 70 were determined in these cells, and expression was in agreement with that known to occur for in situ urothelium. The cells were also successfully tested for their ability to be stably transfected using expression vectors containing the MT-3 or MT-2A genes. The findings suggest that the UROtsa cells grown with a serum-free medium could be a valuable adjunct for studying environmental insult to the human urothelium in general and for the stress response in particular.
The UROtsa cell line was isolated from a primary culture of normal human urothelium through immortalization with a construct containing the SV40 large T antigen. It proliferates in serum-containing growth medium as a cell monolayer with little evidence of uroepithelial differentiation. The working hypothesis in the present study was that this cell line could be induced to differentiate and express known features of in situ urothelium if the original serum-containing growth medium was changed to a serum-free formulation. We demonstrated that the UROtsa cells could be successfully placed into a serum-free growth medium consisting of a 1:1 mixture of Dulbeco's modified Eagle's medium and Ham's F-12 supplemented with selenium (5 ng/mL), insulin (5 microg/mL), transferrin (5 microg/mL), hydrocortisone (36 ng/mL), triiodothyronine (4 pg/mL), and epidermal growth factor (10 ng/mL). Under serum-free growth conditions, confluent UROtsa cells were shown by light microscopy to produce raised, three-dimensional structures. Routine ultrastructural examination disclosed these three-dimensional areas to consist of a stratified layer of cells that strongly resembled in situ urothelium. The cells displayed numerous desmosomal connections, complex interactions of the lateral membranes, and abundant intermediate filaments within the cytoplasm. Freeze fracture analysis demonstrated that the cells possessed tight-junction sealing strands and gap junctions. The overall morphology was most consistent with that found in the intermediate layers of in situ urothelium. The basal expression patterns of the metallothionein (MT) and heat shock proteins 27, 60, and 70 were determined in these cells, and expression was in agreement with that known to occur for in situ urothelium. The cells were also successfully tested for their ability to be stably transfected using expression vectors containing the MT-3 or MT-2A genes. The findings suggest that the UROtsa cells grown with a serum-free medium could be a valuable adjunct for studying environmental insult to the human urothelium in general and for the stress response in particular.
The UROtsa cell line was isolated from a primary culture of normal human urothelium through immortalization with a construct containing the SV40 large T antigen. It proliferates in serum-containing growth medium as a cell monolayer with little evidence of uroepithelial differentiation. The working hypothesis in the present study was that this cell line could be induced to differentiate and express known features of in situ urothelium if the original serum-containing growth medium was changed to a serum-free formulation. We demonstrated that the UROtsa cells could be successfully placed into a serum-free growth medium consisting of a 1:1 mixture of Dulbeco's modified Eagle's medium and Ham's F-12 supplemented with selenium (5 ng/mL), insulin (5 microg/mL), transferrin (5 microg/mL), hydrocortisone (36 ng/mL), triiodothyronine (4 pg/mL), and epidermal growth factor (10 ng/mL). Under serum-free growth conditions, confluent UROtsa cells were shown by light microscopy to produce raised, three-dimensional structures. Routine ultrastructural examination disclosed these three-dimensional areas to consist of a stratified layer of cells that strongly resembled in situ urothelium. The cells displayed numerous desmosomal connections, complex interactions of the lateral membranes, and abundant intermediate filaments within the cytoplasm. Freeze fracture analysis demonstrated that the cells possessed tight-junction sealing strands and gap junctions. The overall morphology was most consistent with that found in the intermediate layers of in situ urothelium. The basal expression patterns of the metallothionein (MT) and heat shock proteins 27, 60, and 70 were determined in these cells, and expression was in agreement with that known to occur for in situ urothelium. The cells were also successfully tested for their ability to be stably transfected using expression vectors containing the MT-3 or MT-2A genes. The findings suggest that the UROtsa cells grown with a serum-free medium could be a valuable adjunct for studying environmental insult to the human urothelium in general and for the stress response in particular.The UROtsa cell line was isolated from a primary culture of normal human urothelium through immortalization with a construct containing the SV40 large T antigen. It proliferates in serum-containing growth medium as a cell monolayer with little evidence of uroepithelial differentiation. The working hypothesis in the present study was that this cell line could be induced to differentiate and express known features of in situ urothelium if the original serum-containing growth medium was changed to a serum-free formulation. We demonstrated that the UROtsa cells could be successfully placed into a serum-free growth medium consisting of a 1:1 mixture of Dulbeco's modified Eagle's medium and Ham's F-12 supplemented with selenium (5 ng/mL), insulin (5 microg/mL), transferrin (5 microg/mL), hydrocortisone (36 ng/mL), triiodothyronine (4 pg/mL), and epidermal growth factor (10 ng/mL). Under serum-free growth conditions, confluent UROtsa cells were shown by light microscopy to produce raised, three-dimensional structures. Routine ultrastructural examination disclosed these three-dimensional areas to consist of a stratified layer of cells that strongly resembled in situ urothelium. The cells displayed numerous desmosomal connections, complex interactions of the lateral membranes, and abundant intermediate filaments within the cytoplasm. Freeze fracture analysis demonstrated that the cells possessed tight-junction sealing strands and gap junctions. The overall morphology was most consistent with that found in the intermediate layers of in situ urothelium. The basal expression patterns of the metallothionein (MT) and heat shock proteins 27, 60, and 70 were determined in these cells, and expression was in agreement with that known to occur for in situ urothelium. The cells were also successfully tested for their ability to be stably transfected using expression vectors containing the MT-3 or MT-2A genes. The findings suggest that the UROtsa cells grown with a serum-free medium could be a valuable adjunct for studying environmental insult to the human urothelium in general and for the stress response in particular.
The UROtsa cell line was tested to determine if it fulfilled the requirements as a cell culture model of human urothelium. The cell line was derived from the normal urothelium lining of the ureter and was immortalized using the simian virus 40 large T antigen. Light and electron microscopy was used to show that propagation of the UROtsa cell line on a serum-free growth medium resulted in expression of structural features of differentiated urothelium. The resulting cultures retained the metallothionein and heat shock protein expression background expected from normal urothelium and could be transfected stably to overexpress the metallothionein-3 gene or knock-out metallothionein gene expression using an antisense vector.
Audience Academic
Author John R. W. Masters
Sens, Donald A.
Garrett, Scott H.
Nath, Joginder
Somji, Seema
Park, Seongmi
Rossi, Michael R.
Sens, Mary Ann
Todd, John H.
AuthorAffiliation Genetics and Developmental Biology Program, West Virginia University, Morgantown, West Virginia, USA
AuthorAffiliation_xml – name: Genetics and Developmental Biology Program, West Virginia University, Morgantown, West Virginia, USA
Author_xml – sequence: 1
  givenname: Michael R.
  surname: Rossi
  fullname: Rossi, Michael R.
– sequence: 2
  fullname: John R. W. Masters
– sequence: 3
  givenname: Seongmi
  surname: Park
  fullname: Park, Seongmi
– sequence: 4
  givenname: John H.
  surname: Todd
  fullname: Todd, John H.
– sequence: 5
  givenname: Scott H.
  surname: Garrett
  fullname: Garrett, Scott H.
– sequence: 6
  givenname: Mary Ann
  surname: Sens
  fullname: Sens, Mary Ann
– sequence: 7
  givenname: Seema
  surname: Somji
  fullname: Somji, Seema
– sequence: 8
  givenname: Joginder
  surname: Nath
  fullname: Nath, Joginder
– sequence: 9
  givenname: Donald A.
  surname: Sens
  fullname: Sens, Donald A.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11564615$$D View this record in MEDLINE/PubMed
BookMark eNqNktFv0zAQxiM0xLrBG8_ID4B4IMN2HMd5QZoqYJWKisYKj5brnBtPTlxiBwF_PZ66sRYNMfnBku93d9_5vqPsoPc9ZNlTgk8IFfUbaDcnmBBcC0weZBNSljSva8oOsgnGNcl5xcvD7CiES4wxEZw_yg4JKTnjpJxkXy9aQLOu80NUzv6CBi3PFzEoNAXn0Nz2gFRACn3yEfpoldsGpqOL4wDoo2_AIW_Q2dipHi0HH1twduweZw-NcgGeXN_H2fL9u4vpWT5ffJhNT-e5rrCIudFUGLEShBsBK96wihADjSkNXjEFq7LWwlSsIbUmXFdFGkiXmpuiooXgAMVx9nZbdzOuOmh0EjkoJzeD7dTwU3pl5X6kt61c---SUIYZrlKBl9cFBv9thBBlZ4NOM6oe_BhkElTVhOP_gkSQoqzxPUBW1hWlIoGvt-BaOZC2Nz4p1GvoIQlNSzY2PZ8KXDFGOUt4fgeeTgOd1Xfxr_b4hET4EddqDEHOPp_fG1182UNf7KAtKBfb4N0Yre_DHvdsdzF_NnJjvdvp9eBDGMDcIlheOVsmZ8sbZyec_oVrG9VV1_QL1v0r6fk26TJEP-w2oAWuZMFKJigtfgNcFgR5
CitedBy_id crossref_primary_10_1016_j_taap_2008_10_013
crossref_primary_10_1002_em_20496
crossref_primary_10_1371_journal_pone_0107530
crossref_primary_10_1371_journal_pone_0122766
crossref_primary_10_3390_stresses1020009
crossref_primary_10_1007_s10565_010_9169_z
crossref_primary_10_1007_s00210_014_0973_5
crossref_primary_10_1093_carcin_bgn102
crossref_primary_10_1016_j_taap_2017_05_007
crossref_primary_10_3390_stresses1020007
crossref_primary_10_1186_1475_2867_12_16
crossref_primary_10_1002_jbm_b_34021
crossref_primary_10_1186_1471_2407_14_310
crossref_primary_10_1371_journal_pone_0156310
crossref_primary_10_1111_bcpt_12799
crossref_primary_10_1016_j_toxlet_2010_08_020
crossref_primary_10_3892_ijmm_2012_1185
crossref_primary_10_1097_01_ju_0000134880_55119_cf
crossref_primary_10_3390_molecules27196488
crossref_primary_10_1016_j_tox_2011_10_006
crossref_primary_10_1289_ehp_10279
crossref_primary_10_1371_journal_pgen_1000917
crossref_primary_10_1371_journal_pone_0016595
crossref_primary_10_1016_j_biomaterials_2010_04_054
crossref_primary_10_1371_journal_pone_0049341
crossref_primary_10_7554_eLife_71184
crossref_primary_10_1016_j_omtn_2017_04_012
crossref_primary_10_1186_1471_2407_9_377
crossref_primary_10_1016_j_urolonc_2014_12_009
crossref_primary_10_1002_path_4892
crossref_primary_10_1016_j_taap_2009_08_016
crossref_primary_10_1016_j_taap_2009_08_019
crossref_primary_10_1016_j_taap_2011_10_002
crossref_primary_10_1016_j_taap_2016_12_011
crossref_primary_10_1007_s11255_018_1831_z
crossref_primary_10_1128_IAI_00074_10
crossref_primary_10_1016_j_toxrep_2014_07_004
crossref_primary_10_1177_0748233712456064
crossref_primary_10_1186_1471_2407_14_214
crossref_primary_10_1016_j_toxlet_2013_07_026
crossref_primary_10_1128_IAI_05005_11
crossref_primary_10_1371_journal_pone_0152055
crossref_primary_10_3390_cancers16173108
crossref_primary_10_1016_j_cancergencyto_2010_07_135
crossref_primary_10_1093_carcin_bgx011
crossref_primary_10_1038_nm1407
crossref_primary_10_1016_j_toxlet_2012_05_003
crossref_primary_10_1007_s00441_010_1053_x
crossref_primary_10_1371_journal_pone_0085614
crossref_primary_10_1016_j_etp_2016_08_003
crossref_primary_10_1371_journal_pone_0015904
crossref_primary_10_1186_s12915_023_01683_2
crossref_primary_10_1371_journal_pone_0129648
crossref_primary_10_3389_fcimb_2021_691210
crossref_primary_10_1093_toxsci_kfj174
crossref_primary_10_1681_ASN_2018090929
crossref_primary_10_1038_sj_bjc_6602593
crossref_primary_10_1016_j_tox_2011_11_002
crossref_primary_10_1038_s41467_017_02097_9
crossref_primary_10_1007_s00580_021_03233_0
crossref_primary_10_1016_j_tiv_2007_06_021
crossref_primary_10_1186_1471_2490_13_42
crossref_primary_10_3390_ijms25031851
crossref_primary_10_1093_toxsci_kfi231
crossref_primary_10_1016_j_juro_2006_06_088
crossref_primary_10_1007_s10495_010_0535_3
crossref_primary_10_1007_s10103_021_03367_1
crossref_primary_10_2353_ajpath_2010_090552
crossref_primary_10_4161_epi_22163
crossref_primary_10_1186_1471_2407_11_168
crossref_primary_10_1093_toxsci_kfl065
crossref_primary_10_1038_s41598_020_79882_y
crossref_primary_10_1371_journal_pone_0147362
crossref_primary_10_1096_fj_201900499RR
crossref_primary_10_1371_journal_pone_0207877
crossref_primary_10_1038_ki_2012_410
crossref_primary_10_1002_jat_1513
crossref_primary_10_1016_j_taap_2019_04_021
crossref_primary_10_1002_chem_201001538
crossref_primary_10_3390_toxics9050094
crossref_primary_10_1371_journal_pone_0064139
crossref_primary_10_1016_j_tox_2008_03_020
crossref_primary_10_1016_j_envres_2009_08_012
crossref_primary_10_1007_s11523_015_0386_5
crossref_primary_10_1371_journal_ppat_1001010
crossref_primary_10_1080_15548627_2020_1733262
crossref_primary_10_1289_ehp_1408302
crossref_primary_10_1002_jbm_a_35544
crossref_primary_10_1093_toxsci_kfm302
crossref_primary_10_1093_toxsci_kfq106
crossref_primary_10_1016_j_urology_2011_02_040
crossref_primary_10_1097_01_LAB_0000035022_29742_85
crossref_primary_10_1124_dmd_107_019034
crossref_primary_10_1016_j_phrs_2011_06_009
crossref_primary_10_1016_j_toxlet_2017_08_013
crossref_primary_10_1016_j_taap_2011_08_029
crossref_primary_10_1158_0008_5472_CAN_10_3072
crossref_primary_10_1371_journal_pone_0127628
crossref_primary_10_1186_1478_811X_3_10
crossref_primary_10_1007_s00432_015_1942_1
crossref_primary_10_1002_elps_201100220
ContentType Journal Article
Copyright COPYRIGHT 2001 National Institute of Environmental Health Sciences
Copyright_xml – notice: COPYRIGHT 2001 National Institute of Environmental Health Sciences
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
7ST
C1K
SOI
7U7
7X8
5PM
DOI 10.1289/ehp.01109801
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
Environment Abstracts
Environmental Sciences and Pollution Management
Environment Abstracts
Toxicology Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Environment Abstracts
Environmental Sciences and Pollution Management
Toxicology Abstracts
MEDLINE - Academic
DatabaseTitleList Toxicology Abstracts

MEDLINE
MEDLINE - Academic
Environment Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1552-9924
EndPage 808
ExternalDocumentID PMC1240407
A80744264
11564615
10_1289_ehp_01109801
3454822
Genre Journal Article
GroupedDBID ---
-~X
.GJ
04C
29G
2WC
2XV
36B
3O-
42X
4P2
53G
5GY
5RE
5VS
6PF
85S
9K5
AACGO
AAFWJ
AANCE
AAWTL
ABBHK
ABDBF
ABOCM
ABPLY
ABPPZ
ABTLG
ABXSQ
ACGFO
ACHIC
ACIHN
ACIWK
ACNCT
ACPRK
ACUHS
ADBBV
ADOJX
ADQXQ
ADRAZ
ADULT
AEAQA
AENEX
AEUPB
AEXZC
AFPKN
AFRAH
AGNAY
AHDLI
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ANHSF
AOIJS
AQVQM
AS~
AXR
B0M
BAWUL
BCNDV
C1A
CS3
DCCCD
DIK
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EBX
ECF
ECGQY
EDH
EHB
EHC
EHE
EHN
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
F8P
GROUPED_DOAJ
GX1
H13
HGD
HQ3
HTVGU
HYE
I-F
IAG
IAO
IEA
IEP
IER
IHR
IHW
INH
INR
IOF
IOV
IPO
IPSME
ISR
ITC
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
KQ8
M48
O5R
O5S
OK1
OVT
P2P
PGMZT
QF4
QM9
QN7
QO4
REH
RGD
RPM
SA0
SJN
SV3
TAN
TR2
TUS
U5U
UDP
UGJ
WH7
WOQ
WOW
XSB
YR5
ZE2
ZGI
~02
~8M
~KM
7RV
7WY
7X7
7XC
88E
8AO
8C1
8FE
8FG
8FH
8FI
8FJ
8FL
8G5
8R4
8R5
AAYXX
ABJCF
ABUWG
AEUYN
AFFHD
AFKRA
AN0
ATCPS
AZQEC
BANNL
BENPR
BES
BEZIV
BGLVJ
BHPHI
BKEYQ
BKNYI
BMSDO
BNQBC
BPHCQ
BVXVI
CCPQU
CITATION
DWQXO
ECT
EIHBH
EPT
EX3
FRNLG
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
K60
K6~
K9-
L6V
M0C
M0R
M1P
M2O
M7S
NAPCQ
NEJ
PATMY
PCD
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQBIZ
PQBZA
PQGLB
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
Q2X
Q~Q
RNS
RWL
RZL
S0X
TAE
UKHRP
WQ9
ZAC
3V.
ADZLD
CGR
CUY
CVF
DOOOF
ECM
EIF
EQZMY
JSODD
M~E
NPM
PKN
7ST
C1K
SOI
7U7
7X8
5PM
ID FETCH-LOGICAL-c708t-fc28f8b816f8eb6d4711fedf5f0b4aeb59c8f74d19c16c73091c5c6f372386ee3
ISICitedReferencesCount 124
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000170851700023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0091-6765
IngestDate Thu Aug 21 18:42:54 EDT 2025
Fri Sep 05 13:59:47 EDT 2025
Mon Oct 06 17:59:37 EDT 2025
Tue Oct 07 07:43:01 EDT 2025
Sat Nov 29 12:53:27 EST 2025
Mon Nov 24 15:44:49 EST 2025
Wed Nov 26 09:30:06 EST 2025
Wed Nov 26 09:23:45 EST 2025
Thu May 22 21:22:50 EDT 2025
Wed Feb 19 02:43:24 EST 2025
Tue Nov 18 21:57:00 EST 2025
Sat Nov 29 02:41:13 EST 2025
Thu Jul 03 21:13:52 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c708t-fc28f8b816f8eb6d4711fedf5f0b4aeb59c8f74d19c16c73091c5c6f372386ee3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink http://dx.doi.org/10.1289/ehp.01109801
PMID 11564615
PQID 14597228
PQPubID 23462
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_1240407
proquest_miscellaneous_71179160
proquest_miscellaneous_18135900
proquest_miscellaneous_14597228
gale_infotracgeneralonefile_A80744264
gale_infotracacademiconefile_A80744264
gale_incontextgauss_ISR_A80744264
gale_incontextgauss_IOV_A80744264
gale_healthsolutions_A80744264
pubmed_primary_11564615
crossref_primary_10_1289_ehp_01109801
crossref_citationtrail_10_1289_ehp_01109801
jstor_primary_10_2307_3454822
PublicationCentury 2000
PublicationDate 2001-08-01
PublicationDateYYYYMMDD 2001-08-01
PublicationDate_xml – month: 08
  year: 2001
  text: 2001-08-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Environmental health perspectives
PublicationTitleAlternate Environ Health Perspect
PublicationYear 2001
Publisher National Institute of Environmental Health Sciences. National Institutes of Health. Department of Health, Education and Welfare
National Institute of Environmental Health Sciences
Publisher_xml – name: National Institute of Environmental Health Sciences. National Institutes of Health. Department of Health, Education and Welfare
– name: National Institute of Environmental Health Sciences
References 10559632 - Exp Nephrol. 1999 Sep-Dec;7(5-6):344-52
10544156 - Environ Health Perspect. 1999 Nov;107(11):887-93
7663007 - Int J Clin Lab Res. 1995;25(2):59-70
8788275 - Urol Res. 1995;23(6):377-80
1504357 - Microsc Res Tech. 1992 Aug 1;22(3):301-5
10754528 - Prostate. 2000 May 1;43(2):125-35
2630525 - J Anat. 1989 Dec;167:103-15
10379001 - Environ Health Perspect. 1999 Jul;107(7):545-52
9721259 - Environ Health Perspect. 1998 Sep;106(9):587-95
9504712 - Biol Chem. 1998 Jan;379(1):19-26
10517878 - Prostate. 1999 Nov 1;41(3):196-202
6708176 - J Urol. 1984 Apr;131(4):650-4
3708594 - Cancer Res. 1986 Jul;46(7):3630-6
11270423 - Cancer Detect Prev. 2001;25(1):62-75
2793232 - Int J Cancer. 1989 Oct 15;44(4):605-10
7526519 - Urol Res. 1994;22(2):67-74
8280473 - Annu Rev Cell Biol. 1993;9:601-34
10836974 - Am J Physiol Renal Physiol. 2000 Jun;278(6):F867-74
10811567 - Environ Health Perspect. 2000 May;108(5):413-8
2822239 - Cancer Res. 1987 Nov 15;47(22):6066-73
3378220 - Cancer Res. 1988 Jul 1;48(13):3849-52
10329705 - J Biol Chem. 1999 May 21;274(21):15020-9
9831543 - Environ Health Perspect. 1998 Dec;106(12):825-31
10802388 - Toxicol Lett. 2000 May 19;115(2):127-36
9476895 - Cell. 1998 Feb 6;92(3):351-66
13149741 - Br J Ind Med. 1954 Apr;11(2):75-104
8619255 - Toxicol Lett. 1996 Apr;85(1):17-27
References_xml – reference: 2793232 - Int J Cancer. 1989 Oct 15;44(4):605-10
– reference: 10754528 - Prostate. 2000 May 1;43(2):125-35
– reference: 9504712 - Biol Chem. 1998 Jan;379(1):19-26
– reference: 8619255 - Toxicol Lett. 1996 Apr;85(1):17-27
– reference: 9476895 - Cell. 1998 Feb 6;92(3):351-66
– reference: 6708176 - J Urol. 1984 Apr;131(4):650-4
– reference: 3378220 - Cancer Res. 1988 Jul 1;48(13):3849-52
– reference: 13149741 - Br J Ind Med. 1954 Apr;11(2):75-104
– reference: 10802388 - Toxicol Lett. 2000 May 19;115(2):127-36
– reference: 10379001 - Environ Health Perspect. 1999 Jul;107(7):545-52
– reference: 10559632 - Exp Nephrol. 1999 Sep-Dec;7(5-6):344-52
– reference: 8280473 - Annu Rev Cell Biol. 1993;9:601-34
– reference: 10836974 - Am J Physiol Renal Physiol. 2000 Jun;278(6):F867-74
– reference: 10517878 - Prostate. 1999 Nov 1;41(3):196-202
– reference: 7663007 - Int J Clin Lab Res. 1995;25(2):59-70
– reference: 7526519 - Urol Res. 1994;22(2):67-74
– reference: 8788275 - Urol Res. 1995;23(6):377-80
– reference: 10329705 - J Biol Chem. 1999 May 21;274(21):15020-9
– reference: 3708594 - Cancer Res. 1986 Jul;46(7):3630-6
– reference: 2822239 - Cancer Res. 1987 Nov 15;47(22):6066-73
– reference: 9721259 - Environ Health Perspect. 1998 Sep;106(9):587-95
– reference: 10544156 - Environ Health Perspect. 1999 Nov;107(11):887-93
– reference: 11270423 - Cancer Detect Prev. 2001;25(1):62-75
– reference: 1504357 - Microsc Res Tech. 1992 Aug 1;22(3):301-5
– reference: 10811567 - Environ Health Perspect. 2000 May;108(5):413-8
– reference: 9831543 - Environ Health Perspect. 1998 Dec;106(12):825-31
– reference: 2630525 - J Anat. 1989 Dec;167:103-15
SSID ssj0001866
Score 2.0632255
Snippet The UROtsa cell line was isolated from a primary culture of normal human urothelium through immortalization with a construct containing the SV40 large T...
The UROtsa cell line was tested to determine if it fulfilled the requirements as a cell culture model of human urothelium. The cell line was derived from the...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
jstor
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 801
SubjectTerms Cell culture techniques
Cell Culture Techniques - methods
Cell Division
Cell growth
Cell Line
Cell lines
Cell Transformation, Viral
Culture Media
Cultured cells
Dendritic cells
Epithelial cells
Gene Expression
Heat-Shock Proteins - genetics
Humans
Kidney Tubules, Proximal
Messenger RNA
Metallothionein - biosynthesis
Models, Biological
Protein Isoforms - biosynthesis
Protein Isoforms - genetics
RNA
RNA, Antisense - genetics
RNA, Messenger - biosynthesis
Transfection - methods
Ureter - cytology
Urinary bladder
Urothelium
Urothelium - cytology
Title The Immortalized UROtsa Cell Line as a Potential Cell Culture Model of Human Urothelium
URI https://www.jstor.org/stable/3454822
https://www.ncbi.nlm.nih.gov/pubmed/11564615
https://www.proquest.com/docview/14597228
https://www.proquest.com/docview/18135900
https://www.proquest.com/docview/71179160
https://pubmed.ncbi.nlm.nih.gov/PMC1240407
Volume 109
WOSCitedRecordID wos000170851700023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1552-9924
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001866
  issn: 0091-6765
  databaseCode: DOA
  dateStart: 19720101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbK4AEJIe4U2DAS4yVKaNImth-nCbRJY5u661uUOPZWqaTV0k4Tv5sfwDmxc2Mbgwdeoio5SX354nPJOZ8J-SiHiQQrVrih4OCgJAPpCnC03EwreM1TFsqS7fN4h-3u8tNTsd_r_axqYS6nLM_51ZWY_9ephnMw2Vg6-w_TXT8UTsBvmHQ4wrTD8a8nfhv-Ds3qyQ-wJ4_Ge4sicTYxSreDRmVSOImzP1tgohDGDvCCodZU5d5o0ya6f3SBFVrTiSVsqEL4TXVcXUqJBMhV2WaTPw8qeNLKznfGXidlZ-w5J57zLUG2hvqmfZu-faBm-dn3SRMHz7IqedjZ8jrhCr9Ollu02b6n3VyIbrNtAZZd3ArPuX5TmeZi5DxYmecw2lXuhDlbapIqRab8DnOipjqxCcVWGQjfjZjZqqJWBgPRQj1vLe3c9sJaCSUbxXUFBP4rou587qFhJeqbOpTewxH4iQEYDvcDFgpRBQKs_YAUhIY71TTPlmvAkz-3n9sxpKw5YVJqb3KWfs_5bRlRh0_IY-v90A2D2qekp_Jn5JEJHVMzpM_JCSCYthFMDYIpApUigmlS0ITWCDYXLIJpiWA607REMG0Q_IIcff1yuLnl2v0_XMkGfOFqGXDNU-5Hmqs0ysCO8rXKdKgH6ShRaSgk12yU-UL6kQRVJXwZykgPcSO9SKnhS7KSz3L1mlAWRJnWaeYHSmBpp9BaitFAhSoSqdR-nzjVYMbSkuPjHi3TGJ1kGPoYhj6uhr5P1mvpuSGFuUVuDeclNu9hvbjEG8hAha5In3woBZCIJcdMr7NkWRTx9t7x3TIH47bMJyujZ9BsmdjaGug80ru1Bdc7gmeG2_4GudUSSu3uYclIbKHbJ-8riMWgj_AjY5Kr2bKI_VEoWBDwP0hwf4h7Fd8uwZCn0o9A4pUBbdMM5LYCJ6xPWAfOtQCy5Xev5JPzkjUfHBkwWNibO3r2ljxslq13ZGVxsVSr5IG8XEyKizVyj53ytfJ9_QWs7jdZ
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Immortalized+UROtsa+Cell+Line+as+a+Potential+Cell+Culture+Model+of+Human+Urothelium&rft.jtitle=Environmental+health+perspectives&rft.au=Rossi%2C+Michael+R.&rft.au=John+R.+W.+Masters&rft.au=Park%2C+Seongmi&rft.au=Todd%2C+John+H.&rft.date=2001-08-01&rft.pub=National+Institute+of+Environmental+Health+Sciences.+National+Institutes+of+Health.+Department+of+Health%2C+Education+and+Welfare&rft.issn=0091-6765&rft.volume=109&rft.issue=8&rft.spage=801&rft.epage=808&rft_id=info:doi/10.1289%2Fehp.01109801&rft.externalDocID=3454822
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-6765&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-6765&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-6765&client=summon